Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B.

Literature DB >> 7872761

Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B.

Abstract

Cryptococcus neoformans grown with L-dopa was melanized and was less susceptible to amphotericin B. The results suggest that in vivo and in vitro susceptibilities to amphotericin B may differ.

Entities: Chemical Species

Mesh：

Substances：

Year: 1994 PMID： 7872761 PMCID： PMC188256 DOI： 10.1128/AAC.38.11.2648

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

18 in total

1. The free radical property of melanins.

Authors: H S MASON; D J INGRAM; B ALLEN
Journal: Arch Biochem Biophys Date: 1960-02 Impact factor: 4.013

Review 2. Amphotericin B: current understanding of mechanisms of action.

Authors: J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal: Antimicrob Agents Chemother Date: 1990-02 Impact factor: 5.191

3. Catecholamines and virulence of Cryptococcus neoformans.

Authors: I Polacheck; Y Platt; J Aronovitch
Journal: Infect Immun Date: 1990-09 Impact factor: 3.441

4. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice.

Authors: K J Kwon-Chung; I Polacheck; T J Popkin
Journal: J Bacteriol Date: 1982-06 Impact factor: 3.490

5. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.

Authors: S L Chuck; M A Sande
Journal: N Engl J Med Date: 1989-09-21 Impact factor: 91.245

6. New, special stain for histopathological diagnosis of cryptococcosis.

Authors: K J Kwon-Chung; W B Hill; J E Bennett
Journal: J Clin Microbiol Date: 1981-02 Impact factor: 5.948

7. Advantage of Fontana-Masson stain in capsule-deficient cryptococcal infection.

Authors: J Y Ro; S S Lee; A G Ayala
Journal: Arch Pathol Lab Med Date: 1987-01 Impact factor: 5.534

8. Production of diagnostic pigment by phenoloxidase activity of cryptococcus neoformans.

Authors: C E Shaw; L Kapica
Journal: Appl Microbiol Date: 1972-11

9. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

Authors: A Zuger; E Louie; R S Holzman; M S Simberkoff; J J Rahal
Journal: Ann Intern Med Date: 1986-02 Impact factor: 25.391

10. Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans.

Authors: I Polacheck; V J Hearing; K J Kwon-Chung
Journal: J Bacteriol Date: 1982-06 Impact factor: 3.490

35 in total

Review 1. Pathogenic roles for fungal melanins.

Authors: E S Jacobson
Journal: Clin Microbiol Rev Date: 2000-10 Impact factor: 26.132

2. Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans.

Authors: Y Wang; P Aisen; A Casadevall
Journal: Infect Immun Date: 1996-07 Impact factor: 3.441

Review 3. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.

Authors: Joshua D Nosanchuk; Arturo Casadevall
Journal: Antimicrob Agents Chemother Date: 2006-11 Impact factor: 5.191

4. Detection of antibodies against Paracoccidioides brasiliensis melanin in in vitro and in vivo studies during infection.

Authors: Martha E Urán; Joshua D Nosanchuk; Angela Restrepo; Andrew J Hamilton; Beatriz L Gómez; Luz E Cano
Journal: Clin Vaccine Immunol Date: 2011-08-03

Review 5. Immune response and immunotherapy to Cryptococcus infections.

Authors: Qing Zhou; William J Murphy
Journal: Immunol Res Date: 2006 Impact factor: 2.829

6. Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice.

Authors: L Liu; K Wakamatsu; S Ito; P R Williamson
Journal: Infect Immun Date: 1999-01 Impact factor: 3.441

10. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine.

Authors: Y Wang; A Casadevall
Journal: Antimicrob Agents Chemother Date: 1996-03 Impact factor: 5.191